| Clinical comparison of anti-MuSK-vs anti-AChR-positive and seronegative myasthenia gravis F Deymeer, O Gungor-Tuncer, V Yılmaz, Y Parman, P Serdaroglu, ... Neurology 68 (8), 609-611, 2007 | 228 | 2007 |
| IL-12 and IL-10 polymorphisms and their effects on cytokine production V Yılmaz, SP Yentür, G Saruhan-Direskeneli Cytokine 30 (4), 188-194, 2005 | 223 | 2005 |
| Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease T Hughes, P Coit, A Adler, V Yilmaz, K Aksu, N Düzgün, G Keser, A Cefle, ... Nature genetics 45 (3), 319-324, 2013 | 161 | 2013 |
| Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey Z Sahin, M Bıcakcıgil, K Aksu, S Kamali, S Akar, F Onen, O Karadag, ... Arthritis research & therapy 14, 1-5, 2012 | 89 | 2012 |
| Activation of the JAK/STAT pathway in Behcet’s disease A Tulunay, MG Dozmorov, F Ture-Ozdemir, V Yilmaz, ... Genes & Immunity 16 (2), 170-175, 2015 | 80 | 2015 |
| Interleukin (IL)–12, IL-2, and IL-6 Gene Polymorphisms in Takayasu’s Arteritis from Turkey G Saruhan-Direskeneli, M Bıçakçıgil, V Yılmaz, S Kamalı, K Aksu, I Fresko, ... Human immunology 67 (9), 735-740, 2006 | 66 | 2006 |
| Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK V Yilmaz, P Oflazer, F Aysal, H Durmus, K Poulas, SP Yentur, ... PloS one 10 (4), e0123546, 2015 | 56 | 2015 |
| Association of HLA-DRB1∗ 14,-DRB1∗ 16 and-DQB1∗ 05 with MuSK-myasthenia gravis in patients from Turkey M Alahgholi-Hajibehzad, V Yilmaz, Y Gülsen-Parman, F Aysal, P Oflazer, ... Human immunology 74 (12), 1633-1635, 2013 | 56 | 2013 |
| Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis G Saruhan-Direskeneli, T Hughes, V Yilmaz, H Durmus, A Adler, ... Clinical Immunology 166, 81-88, 2016 | 49 | 2016 |
| A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease AH Sawalha, T Hughes, A Nadig, V Yılmaz, K Aksu, G Keser, A Cefle, ... Arthritis & Rheumatism 63 (11), 3607-3612, 2011 | 48 | 2011 |
| Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice C Ulusoy, E Kim, E Tüzün, R Huda, V Yılmaz, K Poulas, N Trakas, ... Clinical Immunology 151 (2), 155-163, 2014 | 41 | 2014 |
| Comparison of circulating levels of uremic toxins in hemodialysis patients treated with medium cut-off membranes and high-flux membranes: Theranova in Sisli Hamidiye Etfal (THE … M Sevinc, NB Hasbal, V Yilmaz, T Basturk, E Ahbap, T Sakaci, PN Ozcafer, ... Blood Purification 49 (6), 733-742, 2020 | 38 | 2020 |
| Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease. J Duymaz-Tozkir, V Yilmaz, FA Uyar, AH Hajeer, G Saruhan-Direskeneli, ... The Journal of Rheumatology 32 (1), 93-97, 2005 | 37 | 2005 |
| B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis V Yilmaz, P Oflazer, F Aysal, YG Parman, H Direskeneli, F Deymeer, ... Autoimmunity 48 (4), 201-207, 2015 | 35 | 2015 |
| Interleukin (IL)-12, IL-2, interferon-γ gene polymorphisms in subacute sclerosing panencephalitis patients V Yilmaz, V Demirbilek, C Gürses, SP Yentür, S Uysal, Z Yapici, G Yilmaz, ... Journal of neurovirology 13, 410-415, 2007 | 34 | 2007 |
| Common denominators in the immunobiology of IgG4 autoimmune diseases: what do glomerulonephritis, pemphigus vulgaris, myasthenia gravis, thrombotic thrombocytopenic purpura and … I Koneczny, V Yilmaz, K Lazaridis, J Tzartos, TL Lenz, S Tzartos, E Tüzün, ... Frontiers in immunology 11, 605214, 2021 | 27 | 2021 |
| Long remission in muscle-specific kinase antibody-positive juvenile myasthenia B Anlar, V Yılmaz, G Saruhan-Direskeneli Pediatric neurology 40 (6), 455-456, 2009 | 27 | 2009 |
| Genetic Association of a Gain‐of‐Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet’s Disease L Ortiz Fernandez, P Coit, V Yilmaz, SP Yentür, F Alibaz‐Oner, K Aksu, ... Arthritis & Rheumatology 73 (7), 1244-1252, 2021 | 25 | 2021 |
| Immunization with recombinantly expressed LRP4 induces experimental autoimmune myasthenia gravis in C57BL/6 mice C Ulusoy, F Çavuş, V Yılmaz, E Tüzün Immunological Investigations 46 (5), 490-499, 2017 | 24 | 2017 |
| Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome S Yildiz Celik, H Durmus, V Yilmaz, G Saruhan Direskeneli, ... Acta Neurologica Belgica 120, 133-140, 2020 | 23 | 2020 |
